Pancreatic Cancer Research

ResearcherZhejiang UniversityActive in the last 2 years

Jian Ji

Matched on ORCID iD 0000-0001-9870-4038; OpenAlex author ID A5100613666. Sources: OpenAlex.

Their work

Papers
11 (first author 0, last author 7)
Trials
0
Grants
0
Labs led
1
Collaborators
10
Papers, trials and grants by year

2015: 1 paper · 2016: 2 papers · 2017: 2 papers · 2018: none · 2019: none · 2020: 3 papers · 2021: none · 2022: 2 papers · 2023: none · 2024: 1 paper

Papers 11

  1. Photo-Triggered Cascade Therapy: A NIR-II AIE Luminogen Collaborating with Nitric Oxide Facilitates Efficient Collagen Depletion for Boosting Pancreatic Cancer… Co-author DOI 10.1002/adma.202306476↗
  2. Synchronously boosting type-I photodynamic and photothermal efficacies via molecular manipulation for pancreatic cancer theranostics in the NIR-II window. Co-author DOI 10.1016/j.biomaterials.2022.121476↗
  3. Cancer-Associated Fibroblast-Targeted Delivery of Captopril to Overcome Penetration Obstacles for Enhanced Pancreatic Cancer Therapy. Last author DOI 10.1021/acsabm.2c00486↗
  4. Nitric oxide-induced stromal depletion for improved nanoparticle penetration in pancreatic cancer treatment. Last author DOI 10.1016/j.biomaterials.2020.119999↗
  5. Supramolecular Aggregation-Induced Emission Nanodots with Programmed Tumor Microenvironment Responsiveness for Image-Guided Orthotopic Pancreatic Cancer Therap… Co-author DOI 10.1021/acsnano.0c02197↗
  6. Metformin-Induced Stromal Depletion to Enhance the Penetration of Gemcitabine-Loaded Magnetic Nanoparticles for Pancreatic Cancer Targeted Therapy. Co-author DOI 10.1021/jacs.0c00650↗
  7. Enzyme-sensitive gemcitabine conjugated albumin nanoparticles as a versatile theranostic nanoplatform for pancreatic cancer treatment. Last author DOI 10.1016/j.jcis.2017.07.047↗
  8. Dual Enzymatic Reaction-Assisted Gemcitabine Delivery Systems for Programmed Pancreatic Cancer Therapy. Last author DOI 10.1021/acsnano.6b05541↗
  9. IR-780 Loaded Phospholipid Mimicking Homopolymeric Micelles for Near-IR Imaging and Photothermal Therapy of Pancreatic Cancer. Last author DOI 10.1021/acsami.6b00251↗
  10. Theranostic reduction-sensitive gemcitabine prodrug micelles for near-infrared imaging and pancreatic cancer therapy. Last author DOI 10.1039/c5nr06734k↗
  11. The rational design of a gemcitabine prodrug with AIE-based intracellular light-up characteristics for selective suppression of pancreatic cancer cells. Last author DOI 10.1039/c5cc06654a↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiaohui Chen · 6 shared papers, 2020–2024 · strength 0.97
  2. Haijie Han · 6 shared papers, 2015–2020 · strength 0.47
  3. Dan Li · 2 shared papers, 2022–2024 · strength 0.39
  4. Ben Zhong Tang · 2 shared papers, 2022–2024 · strength 0.39
  5. Yangjun Chen · 3 shared papers, 2015–2016 · strength 0.20
  6. Dan Ding · 1 shared paper, 2020 · strength 0.13
  7. Haibo Wang · 2 shared papers, 2016 · strength 0.13
  8. Muxing Kang · 1 shared paper, 2020 · strength 0.12
  9. Mingyuan Gao · 1 shared paper, 2020 · strength 0.12
  10. Yulian Wu · 1 shared paper, 2017 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.